Overview

Irritable Bowel Syndrome with Constipation Drugs Market is forecasted to value over USD 2.35 billion by 2027 end and register a CAGR of 10% from the forecast period 2020-2027.

FutureWise Market Research has illustrated a report on the Irritable Bowel Syndrome with Constipation Drugs Market. The report provides an in-depth anatomy of the market trends affecting its growth. Moreover, it includes intricate insights on profitability graph, market share, SWOT analysis and geographical augmentation of this business. Furthermore, the report provides information on the status of key market players in the competitive landscape analysis of Irritable Bowel Syndrome with Constipation Drugs Market.
The market is projected to achieve significant growth by the end of the forecast period as per the research study conducted by FutureWise research analysts. The report explains that this business is predicted to record a remarkable growth rate over the forecast period. This report provides important information regarding the total valuation that this industry holds presently and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Irritable Bowel Syndrome with Constipation Drugs market are:    

• Nestle
• Abbot Laboratories
• Synergy Pharmaceuticals
• Sucampo Pharmaceuticals
• Novartis
• Astellas Pharmaceuticals
• Ironwood Pharmaceuticals, Inc.
• Takeda Pharmaceutical Company Limited
• AstraZeneca
• Sebela Pharmaceuticals Inc.
• Synthetic Biologics, Inc.
• Bausch Health

(Note: The list of the major players will be updated with the latest market scenario and trends)

Irritable Bowel Syndrome with Constipation Drugs Market Segmentation:
By Product Type

• Lubiprostone
• Linaclotide
• Stimulant Laxatives
• Osmotic Laxatives
• Lactulose
• Polyethylene Glycol
• Pipeline Drugs
• Plecanatide - Pre registration
• Tenapanor - Phase II
• SYN-010 - Phase II
• Relenopride - Phase II

By Prescription type

• Prescribed Drugs
• Over the Counter Drugs

By Application
• Hospitals
• Clinics
• Others
By Region
• North America
• Europe
• Asia-Pacific
• Rest of the world

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share  
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the market by product type,by prescription type, by application  and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key countries— China, Japan, Korea, India, Singapore, Indonesia, Australia and rest of Asia
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction

           1.1. Objectives of the Study 

           1.2. Market Definition 

           1.3. Market Scope 

                   1.3.1. Years Considered for the Study

                   1.3.2. Market Covered

           1.4. Currency 

           1.5. Limitations 

           1.6. Stakeholders 

 2.  Research Methodology 

           2.1. Research Data 

                   2.1.1. Secondary Data

                           2.1.1.1. Key Data from Secondary Sources

                   2.1.2. Primary Data

                            2.1.2.1. Key Data from Primary Sources

           2.2. Market Size Estimation 

           2.3. Market Breakdown and Data Triangulation 

           2.4. Assumptions for the Study  

3. Executive Summary

           3.1. Market Outlook
           3.2. Segment Outlook
           3.3. Competitive Insights

4. Global Orthopedic Prosthetics Market Variables, Trends & Scope

           4.1. Market Lineage Outlook

           4.2. Penetration and Growth Prospect Mapping

           4.3. Industry Value Chain Analysis

           4.4. Cost Analysis Breakdown

           4.5. Technology Overview

           4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances

5. Global Orthopedic Prosthetics Market Overview

           5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                             5.1.1.1. Increasing focus of Orthopedic Prosthetics Companies on Brand Protection
                             5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                             5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                  5.1.3. Industry Challenges
                             5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Orthopedic Prosthetics Market Analysis Tools
           6.1. Industry Analysis - Porter’s
                   6.1.1. Supplier Power
                   6.1.2. Buyer Power
                   6.1.3. Substitution Threat
                   6.1.4. Threat from New Entrants
                   6.1.5. Competitive Rivalry
           6.2. Pestel Analysis
                   6.2.1. Political Landscape
                   6.2.2. Environmental Landscape
                   6.2.3. Social Landscape
                   6.2.4. Technology Landscape
                   6.2.5. Legal Landscape
           6.3. Major Deals And Strategic Alliances Analysis
                   6.3.1. Joint Ventures
                   6.3.2. Mergers and Acquisitions
                   6.3.3. Licensing and Partnership
                   6.3.4. Technology Collaborations
                   6.3.5. Strategic Divestments
           6.4. Market Entry Strategies
           6.5. Case Studies

7. Global Orthopedic Prosthetics Market, By Product Type Historical Analysis and Forecast 2020-2027 (USD Million)

           7.1. Lubiprostone

           7.2. Linaclotide

           7.3. Stimulant Laxatives

           7.4. Osmotic Laxatives

                   7.4.1.Lactulose

                   7.4.2.Polyethylene Glycol

           7.7. Pipeline Drugs

                   7.5.1. Plecanatide - Pre registration

                   7.5.2. Tenapanor - Phase II

                   7.5.3. SYN-010 - Phase II

                   7.5.4. Relenopride - Phase II
8. Global Orthopedic Prosthetics Market, By Prescription type Historical Analysis and Forecast 2020-2027 (USD Million)
          8.1. Prescribed Drugs

          8.2. Over the Counter Drugs

9. Global Orthopedic Prosthetics Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
          9.1. Hospital

          9.2. Clinics

          9.3. Others
10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)

           10.1. Introduction

           10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019

                     10.2.1. U.S.A

                     10.2.2. Canada

                     10.2.3. Mexico

           10.3. Market Size (USD Million) Forecast for North America 2020-2027 

11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)

           11.1. Introduction

           11.2. Regional Market Trends

           11.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019

                     11.3.1. Brazil

                     11.3.2. Venezuela

                     11.3.3. Argentina

                     11.3.4. Rest of Latin America

           11.4. Market Size (USD Million) Forecast for Latin America 2020-2027  

12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)

           12.1. Introduction

           12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019

                     12.2.1. Germany

                     12.2.2. U.K

                     12.2.3. France

                     12.2.4. Italy

                     12.2.5. Spain

                     12.2.6. Russia

                     12.2.7. Poland

                     12.2.8. Switzerland

                     12.2.9. Rest of Western Europe

           12.3. Market Size (USD Million) Forecast for Europe 2020-2027

13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)

           13.1. Introduction

           13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019

                     13.2.1. Japan

                     13.2.2. China

                     13.2.3. Singapore

                     13.2.4. India

                     13.2.5. Australia and New Zealand

                     13.2.6. ASEAN

                     13.2.7. South Korea

                     13.2.8. Taiwan

                     13.2.9. Rest of Asia Pacific

           13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027

14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)

           14.1. Introduction

           14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019

                     14.2.1. Saudi Arabia

                     14.2.2. UAE

                     14.2.3. South Africa

                     14.2.4. Egypt

           14.3. Market Size (USD Million) Forecast for MEA 2020-2027

15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)

           15.1. Nestle

                     15.1.1. Company Overview

                     15.1.2. Product Portfolio

                     15.1.3. SWOT Analysis

                     15.1.4. Financial Overview

                     15.1.5. Strategic Overview

           15.2. Abbot Laboratories

                     15.2.1. Company Overview

                     15.2.2. Product Portfolio

                     15.2.3. SWOT Analysis

                     15.2.4. Financial Overview

                     15.2.5. Strategic Overview

           15.3. Synergy Pharmaceuticals

                     15.3.1. Company Overview

                     15.3.2. Product Portfolio

                     15.3.3. SWOT Analysis

                     15.3.4. Financial Overview

                     15.3.5. Strategic Overview

           15.4. Sucampo Pharmaceuticals

                     15.4.1. Company Overview

                     15.4.2. Product Portfolio

                     15.4.3. SWOT Analysis

                     15.4.4. Financial Overview

                     15.4.5. Strategic Overview

           15.5 Novartis

                     15.5.1. Company Overview

                     15.5.2. Product Portfolio

                     15.5.3. SWOT Analysis

                     15.5.4. Financial Overview

                     15.5.5. Strategic Overview

           15.6 Astellas Pharmaceuticals

                     15.6.1. Company Overview

                     15.6.2. Product Portfolio

                     15.6.3. SWOT Analysis

                     15.6.4. Financial Overview

                     15.6.5. Strategic Overview

           15.7. Ironwood Pharmaceuticals, Inc.

                     15.7.1. Company Overview

                     15.7.2. Product Portfolio

                     15.7.3. SWOT Analysis

                     15.7.4. Financial Overview

                     15.7.5. Strategic Overview

           15.8. Takeda Pharmaceutical Company Limited

                     15.8.1. Company Overview

                     15.8.2. Product Portfolio

                     15.8.3. SWOT Analysis

                     15.8.4. Financial Overview

                     15.8.5. Strategic Overview

           15.9. AstraZeneca

                     15.9.1. Company Overview

                     15.9.2. Product Portfolio

                     15.9.3. SWOT Analysis

                     15.9.4. Financial Overview

                     15.9.5. Strategic Overview

           15.10. Sebela Pharmaceuticals Inc.

                     15.10.1. Company Overview

                     15.10.2. Product Portfolio

                     15.10.3. SWOT Analysis

                     15.10.4. Financial Overview

                     15.10.5. Strategic Overview

           15.11. Synthetic Biologics, Inc.

                     15.11.1. Company Overview

                     15.11.2. Product Portfolio

                     15.11.3. SWOT Analysis

                     15.11.4. Financial Overview

                     15.11.5. Strategic Overview

           15.12. Bausch Health

                     15.12.1. Company Overview

                     15.12.2. Product Portfolio

                     15.12.3. SWOT Analysis

                     15.12.4. Financial Overview

                     15.12.5. Strategic Overview

16. FutureWise SME Key Takeaway Points for Client

Tables

Figures